$ADMP Naloxone is in the market, Symject is in the market. why this one get 2 CRL!!!! why the FDA did not mention these issues in the first CRL!!!!!. I know Carlo is terrible but FDA work is do bad. does NARCAN owner playing dirty game under the table just to delay the product as long as possible!!!!!!!!!!
  • 3
3 Likes